News and Trends 20 Jul 2023
Biomica announces interim positive results from irritable bowel syndrome program
Biomica Ltd., a clinical-stage biopharmaceutical company developing microbiome-based therapeutics, has released interim positive results from pre-clinical studies in its irritable bowel syndrome (IBS) program. The work was performed in collaboration…